| NLTX Historical PE Ratio (Annualized Method) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
This NLTX PE ratio history page last updated 5/12/2023
| NLTX Historical PE Ratio (TTM Method) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| NLTX Current Stock Quote |
 Free NLTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| NLTX Stock Price Chart |
| Featured Articles |
| Historical PE Peers |
| Neoleukin Therapeutics (NLTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:
NMTC PE Ratio History NMTR PE Ratio History NOTV PE Ratio History NOVN PE Ratio History NPCE PE Ratio History NRBO PE Ratio History NRC PE Ratio History NRIX PE Ratio History NSTG PE Ratio History NTLA PE Ratio History |
How should the NLTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?
✔️Accepted answer:
There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Neoleukin Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this NLTX Historical PE Ratio page.
What is the average historical PE for NLTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?
✔️Accepted answer:
The NLTX historical PE ratio using the annualized quarterly earnings method works out to 6.3.
What is the average historical PE for NLTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?
✔️Accepted answer:
The NLTX historical PE ratio using the TTM earnings method works out to NA.
On this page we presented the NLTX Historical PE Ratio information for Neoleukin Therapeutics' stock.
The average NLTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 6.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NLTX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.Let's now compare this NLTX historical PE result, against the recent PE: when this page was posted on 5/11/2023, the most recent closing price for NLTX had been 0.88, and the most recent quarterly earnings result, annualized, was 0.48. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent NLTX PE on 5/11/2023 based on annualized quarterly EPS was 1.8. Based on NLTX's history, that recent PE is low relative to the historical average, with the recent PE 71.4% lower than the historical average PE across our data set for Neoleukin Therapeutics.
For self directed investors doing their due diligence on NLTX or any other given stock, valuation analysis for NLTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Neoleukin Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NLTX. Thanks for visiting, and the next time you need to research NLTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.